NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Phase2Phase Biopharma

Phase2Phase Biopharma

Overview

Phase2Phase Biopharma is a Swedish life science firm founded in 2017 that provides consulting services and invests its profits in early-stage life science ventures.

Year Founded

2017

Portfolio Companies

4

Investments

Phase2Phase Biopharma investments
CompanyDateStageLead
VakonaApr 2025VC RoundCo-investor
AAX Biotech ABOct 2024VC RoundCo-investor
Key2BrainOct 2024VC RoundCo-investor
VakonaMar 2023VC RoundCo-investor
Akiram TherapeuticsJan 2023VC RoundCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersStockholm
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.